Maobai Liu

8PUBLICATIONS
9CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsPharmacogenomicsEnvironmental epidemiologyTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 01, 2025
Cost-effectiveness of sequential treatment strategies involving first-line pembrolizumab with trastuzumab and chemotherapy for unresectable metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.

Caicong You, Jiahao Zhang, Jianying Lei

|Aug 04, 2025
Cost-effectiveness of perioperative durvalumab plus neoadjuvant chemotherapy for muscle invasive bladder cancer in the United States.

Caicong You, Jiahao Zhang, Jianying Lei

|Nov 22, 2023
Managing delayed or missed pregabalin doses in patients with focal epilepsy: a Monte Carlo simulation study.

Helin Xie, You Zheng, Chenyu Wang

|Aug 16, 2022
Effects of eHealth Interventions on Quality of Life and Psychological Outcomes in Cardiac Surgery Patients: Systematic Review and Meta-analysis.

Ruping Ni, Maobai Liu, Shunmin Huang

|Aug 11, 2022
Efficacy of non-pharmacological interventions in pain relief and opioid consumption after cardiac surgery: A systematic review and Bayesian network meta-analysis.

Maobai Liu, Ruping Ni, Shunmin Huang

|Jun 07, 2021
Cost-Effectiveness Analysis of Dacomitinib versus Gefitinib in the First-Line Treatment of EGFR-Positive Advanced or Metastatic Non-Small Cell Lung Cancer.

Longfeng Zhang, Na Li, Maobai Liu

Pageof 2

Frequent Collaborators

3 joint publications

Hongfu Cai

2 joint publications

Ruping Ni

2 joint publications

Shunmin Huang

2 joint publications

Jing Yang